Infinity Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing novel medicines for people with cancer. It focuses on its drug development segment. The company was founded by Steven H. Holtzman and Matthew D. Shair on March 22, 1995 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Infinity Pharmaceuticals Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Infinity Pharmaceuticals Inc. market cap is $100.00.
What is the 52-week high for Infinity Pharmaceuticals Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Infinity Pharmaceuticals Inc. 52 week high is $0.0001 as of September 07, 2025.
What is the 52-week low for Infinity Pharmaceuticals Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Infinity Pharmaceuticals Inc. 52 week low is $0.00 as of September 07, 2025.
What is the 50-day moving average of Infinity Pharmaceuticals Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Infinity Pharmaceuticals Inc. 50-day moving average is $0.00.
